PE12098A1 - Composiciones y metodos para tratar transtornos respiratorios - Google Patents

Composiciones y metodos para tratar transtornos respiratorios

Info

Publication number
PE12098A1
PE12098A1 PE1996000570A PE00057096A PE12098A1 PE 12098 A1 PE12098 A1 PE 12098A1 PE 1996000570 A PE1996000570 A PE 1996000570A PE 00057096 A PE00057096 A PE 00057096A PE 12098 A1 PE12098 A1 PE 12098A1
Authority
PE
Peru
Prior art keywords
compositions
methods
alkyl
formula
respiratory disorders
Prior art date
Application number
PE1996000570A
Other languages
English (en)
Spanish (es)
Inventor
Donald Kay Riker
Ronald Dean Cramer
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE12098A1 publication Critical patent/PE12098A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PE1996000570A 1995-07-28 1996-07-26 Composiciones y metodos para tratar transtornos respiratorios PE12098A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50877595A 1995-07-28 1995-07-28
US61152896A 1996-03-05 1996-03-05

Publications (1)

Publication Number Publication Date
PE12098A1 true PE12098A1 (es) 1998-04-19

Family

ID=27056302

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1996000570A PE12098A1 (es) 1995-07-28 1996-07-26 Composiciones y metodos para tratar transtornos respiratorios

Country Status (8)

Country Link
EP (1) EP0841947A1 (ja)
JP (1) JPH11510168A (ja)
AR (1) AR003470A1 (ja)
AU (1) AU6599196A (ja)
CA (1) CA2227958A1 (ja)
CO (1) CO4750820A1 (ja)
PE (1) PE12098A1 (ja)
WO (1) WO1997004808A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US5770618A (en) * 1996-11-13 1998-06-23 Nastech Pharmaceutical Company, Inc. Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
KR20010024187A (ko) * 1997-09-19 2001-03-26 데이비드 엠 모이어 호흡기 질환의 치료를 위한 조성물 및 방법
DE60232445D1 (de) 2001-06-28 2009-07-09 Ucb Farchim Sa Cetirizin und pseudoephedrin enthaltende tablette
HUP0402299A3 (en) * 2001-09-04 2008-04-28 Boehringer Ingelheim Int Anti-influenza drugs containing ambroxol and bromhexine and process for its preparation
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
FR2865648B1 (fr) 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
RU2286770C2 (ru) * 2004-11-22 2006-11-10 Закрытое акционерное общество "Научно-производственное объединение "Антивирал" (ЗАО "НПО "Антивирал") Антигриппозное средство
JP5598108B2 (ja) * 2009-07-09 2014-10-01 ライオン株式会社 内服用固形組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222406A (ja) * 1983-06-01 1984-12-14 Teijin Ltd 歯周疾患治療用製剤及びその製造法
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
CA2092566A1 (en) * 1990-09-28 1992-03-29 Thomas N. Gates Ibuprofen-antihistamine combinations
DE69229880T2 (de) * 1991-11-19 2000-05-04 The University Of Virginia Patent Foundation, Charlottesville Kombinierte virustatikum-antimediator-behandlung (covam) von gewöhnlichen erkältungen
GB9222849D0 (en) * 1992-10-31 1992-12-16 Smithkline Beecham Plc Novel use of pharmaceutical compositions
BR9307697A (pt) * 1992-12-21 1999-05-25 Procter & Gamble Composições contendo cafeína e s(+)-ibuprofeno ou s(+)-flubiprofeno ou s(+)-quetoprofeno

Also Published As

Publication number Publication date
AR003470A1 (es) 1998-08-05
JPH11510168A (ja) 1999-09-07
AU6599196A (en) 1997-02-26
EP0841947A1 (en) 1998-05-20
WO1997004808A1 (en) 1997-02-13
CO4750820A1 (es) 1999-03-31
CA2227958A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
ATE109970T1 (de) Cyclosporin-augenmittel.
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
BR9806157A (pt) Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose
CO5011115A1 (es) Compuestos y metodos quimioquina
AU2002225772A1 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
BR0111800A (pt) Combinações de inibidores de depeptidil peptidase iv e outros agentes antidiabéticos para o tratamento de diabete mellitus
PE12098A1 (es) Composiciones y metodos para tratar transtornos respiratorios
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
CO5150232A1 (es) METODO Y COMBINACION QUE UTILIZAN (+) NORCISAPRIDA EN COMBINACION CON INHIBIDORES DE BOMBA DE PROTONES O ANTAGONISTAS DEL RECEPTOR H[sub 2]
AR020803A1 (es) Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento
GB2075341B (en) Pharmaceutical compositions
BR9916860A (pt) Método de reduzir colesterol do sangue e/outriglicerìdios do sangue em um indivìduo mamìfero,preparação em forma de unidade de dosagem, e,conjunto para administrar oralmente a mesma
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
PA8542901A1 (es) Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple
CO5011084A1 (es) Composiciones y metodos para tratar trastornos respiratorios
ES2116663T3 (es) Compuestos intermediarios para la preparacion de derivados triterpenos antagonistas del receptor de endotelina.
BR0014895A (pt) Formulação lìquida estável, processo para a preparação da mesma, uso da mesma, uso de polietileno glicol e sal de sódio ou potássio de um inibidor h+, k+-atpase, e, método para tratar doenças gastrointestinais
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
CA2218028A1 (en) Brain edema inhibitor
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
NO982863L (no) Nye forbindelser med analgetisk effekt
NO923198D0 (no) Terapeutiske midler
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları

Legal Events

Date Code Title Description
FA Abandonment or withdrawal